Catalyst

Slingshot members are tracking this event:

Bristol-Myers Squibb (BMY) and Pfizer (PFE) to Present New Analyses of Eliquis (apixaban) Clinical and Real-World Data at the American College of Cardiology 2017 Scientific Session taking place March 17-19

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
BMY Community voting in process
PFE Community voting in process
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Apixaban, Eliquis